Abstract:Tumor necrosis factor (TNF)/inducible nitric oxide synthase (iNOS)-producing dendritic cells (Tip-DCs) have profound impacts on host immune responses during infections. The mechanisms regulating Tip-DC development remain largely unknown. Here, using a mouse model of infection with African trypanosomes, we show that a deficiency in interleukin-27 receptor (IL-27R) signaling results in escalated intrahepatic accumulation of Ly6C-positive (Ly6C + ) monocytes and their differentiation into Tip-DCs. Blocking Tip-DC development significantly ameliorates liver injury and increases the survival of infected IL-27R −/− mice. Mechanistically, Ly6C + monocyte differentiation into pathogenic Tip-DCs in infected IL-27R −/− mice is driven by a CD4 + T cell-interferon gamma (IFN-γ) axis via cell-intrinsic IFN-γ signaling. In parallel, hyperactive IFN-γ signaling induces cell death of Ly6C-negative (Ly6C − ) monocytes in a cell-intrinsic manner, which in turn aggravates the development of pathogenic Tip-DCs due to the loss of the negative regulation of Ly6C − monocytes on Ly6C + monocyte differentiation into Tip-DCs. Thus, IL-27 inhibits the dual-track exacerbation of Tip-DC development induced by a CD4 + T cell–IFN-γ axis. We conclude that IL-27 negatively regulates Tip-DC development by preventing the cell-intrinsic effects of IFN-γ and that the regulation involves CD4 + T cells and Ly6C − monocytes. Targeting IL-27 signaling may manipulate Tip-DC development for therapeutic intervention. IMPORTANCE TNF/iNOS-producing dendritic cells (Tip-DCs) are at the front line as immune effector cells to fight off a broad range of invading microbes. Excessive development of Tip-DCs contributes to tissue destruction. Thus, identifying master regulators of Tip-DC development is fundamental for developing new therapeutic strategies. Here, we identify Tip-DCs as a terminal target of IL-27, which prevents Tip-DC-mediated early mortality during parasitic infections. We demonstrate that IL-27 inhibits Tip-DC development via a dual-track mechanism involving the complex interactions of effector CD4 + T cells, Ly6C − monocytes, and Ly6C + monocytes. These findings delineate an in-depth view of mechanisms of Tip-DC differentiation that may have significant implications for the ongoing development of IL-27-based immunotherapy.

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39

IL-27: Important Factor to Keep Immune Balance

IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation

IL-27 Suppresses the Production of IL-22 in Human CD4(+) T Cells by Inducing the Expression of SOCS1.

IL-27 Disturbs Lipid Metabolism and Restrains Mitochondrial Activity to Inhibit Γδ T17 Cell-Mediated Skin Inflammation

Differential Effect of Il-27 on Developing Versus Committed Th17 Cells

Distinct Role of IL-27 in Immature and LPS-Induced Mature Dendritic Cell-Mediated Development of CD4+ CD127+3G11+ Regulatory T Cell Subset

[Progress on Interleukin-27 in Tumor Immunity].

IL-27 and TCR Stimulation Promote T Cell Expression of Multiple Inhibitory Receptors

IL-27 Signaling Negatively Regulates FcɛRI-mediated Mast Cell Activation and Allergic Response

Systemic Delivery of IL-27 by an Adeno-Associated Viral Vector Inhibits T Cell-Mediated Colitis and Induces Multiple Inhibitory Pathways in T Cells

IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer

IL-27 Negatively Regulates Tip-DC Development during Infection

A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells.

DC-derived IL-27 Suppresses Anti-Tumor Immunity Via the Modulation of Gut Microbiota

Committed Tc17 Cells Are Phenotypically and Functionally Resistant to the Effects of IL-27.

Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells

IL-27p28 Inhibits Central Nervous System Autoimmunity by Concurrently Antagonizing Th1 and Th17 Responses

The Role of IL-27 in the Induction of Anti-Tumor Cytotoxic T Lymphocyte Response.

IL-27–producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases

An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell Subsets